Results 101 to 110 of about 27,782 (204)
Background and Purpose Obesity involves profound disruptions in neuronal circuits, neuroendocrine communication and the endocannabinoid system. While global blockade of cannabinoid CB1 receptors improves metabolism, its clinical use is limited by neuropsychiatric side effects.
Oriane Onimus +7 more
wiley +1 more source
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley +1 more source
Abstract The ascomycetous fungus Cryphonectria carpinicola is typically found in its asexual form on the European hornbeam, and its sexual state has only recently been discovered in deadwood of different Carpinus species in Japan. Recently, this fungus has been added to the EPPO Alert List due to its increasing incidence in the EPPO region and a ...
Carolina Cornejo +2 more
wiley +1 more source
Nondestructive Testing of Welded Composite Metal Foams
X‐ray computed tomography (CT) is used to evaluate welded steel–steel composite metal foam (CMF) joints of two density classes. It reports variation in postweld spatial void distribution and correlates it to weld‐induced changes, mechanical performance, and failure within welded CMF panels.
Chinmaya Prerana Inguva +2 more
wiley +1 more source
Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development
Pharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
Andreas Halman, Ross Corriden
wiley +1 more source
AB-MDMSBA-Not a Synthetic Cannabinoid Receptor Agonist. [PDF]
Patel M +4 more
europepmc +1 more source
Don't Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model. [PDF]
Murataeva N +3 more
europepmc +1 more source
Genomic and structural analysis of the endocannabinoid system in Moroccans: A novel CNR1 variant (V392A) impairs CB1 receptor stability. [PDF]
Abbou H +7 more
europepmc +1 more source
Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models. [PDF]
von Borcke N +4 more
europepmc +1 more source
Receptor-Selective Modulation of Cannabinoid Signaling by Cardamonin: Integrating Molecular Dynamics, Free Energy Calculations, and Behavioral Validation. [PDF]
Khalid MH +7 more
europepmc +1 more source

